Navigation Links
Major Restless Legs Study Completes Enrollment With Support From MediciGlobal

KING OF PRUSSIA, Pa., March 31 /PRNewswire/ -- Successful and seamless completion of clinical trial enrollment requires careful forecasting of screened to randomized patients, market research, an effective recruitment strategy, and project management guided by real time metrics.

MediciGlobal's President and CEO Liz Moench notes: "This is achievable when clinical trial sites are engaged and motivated to meet timelines." She adds, "We had great team chemistry with the study sponsor -- a major Pharma company -- and clinical trial sites were highly enthusiastic about the recruitment program. They were supported by a very experienced MediciGlobal team."

Restless Legs Syndrome (RLS) involves an irresistible urge to move the legs (medically known as akathisia). It is estimated that 7% to 10% of the general population is affected by RLS and 60% of cases are inherited. A serious and common side effect is sleep disturbance.

The recruitment campaign encouraged those diagnosed with RLS and sleep disturbance to seek out the clinical study. An education based approach reached undiagnosed RLS sufferers. Furthermore, MediciGlobal engaged study sites and the RLS community in the development of materials from the start. This ensured that materials were designed for maximum effectiveness.

RLS affects adults of all ages. It is twice as common in women as in men. While more prevalent in adults older than 60 years of age, about 18% of RLS patients are between the ages of 40 to 60, and 7% between 20 and 40. Every clinical study offers unique characteristics, challenges and opportunities. Since the clinical trial spanned all age groups, the recruitment campaign required a segmented approach. Each direct-response strategy used was carefully tracked for performance and cost effectiveness.

The integrated yet segmented recruitment campaign generated considerable interest, yielding nearly 55,000 web hits and click throughs to the online study screener. The project team paced advertising to each study site, in order to ensure that site staff could handle the workflow and no RLS patients were lost in the screening process.

"The team approached this project in a non traditional way," says Moench. "The sponsor was open and willing to fresh ideas and marketing techniques, and clinical trial site enthusiastically embraced them. The results speak for themselves."

This clinical study builds on a long term relationship between the study sponsor and MediciGlobal, where many recruitment programs for a range of therapeutic areas have been successfully implemented.

SOURCE MediciGlobal
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Major deCODE-led Study Underscores Role of the Brain in Obesity
2. Isogen Launches Major New Facility to Address Global Biopharma Demand
3. MultiVu Video Feed: Major Trial Demonstrates Comparable Accuracy of Virtual Colonoscopy and Standard Colonoscopy
4. Major State Grant Accelerates Research and Development of Novel Cancer Therapy
5. Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of Mr. C Causes Major Interest in the Scientific Community
6. First Ever Study on Alzheimers Disease Treatment in Hispanics Presented at Major Medical Meeting
7. Current and Emerging Drugs Continue to Struggle for Patient Share in the Treatment of Major Depressive Disorder
8. Video: Sanford Healths Journey to Cure Type 1 Diabetes Receives Major Boost
9. Oridion Announces Major Medical Research and Congress Presentations
10. Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia and Daily Functioning in Patients with Co-Morbid Major Depressive Disorder
11. Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer
Post Your Comments:
(Date:11/30/2015)... 30, 2015   VolitionRx Limited (NYSE MKT: VNRX), ... for a broad range of cancer types and other conditions, ... Conference, which will be held December 1 - 3 in in ... will be David Kratochvil , Chief Financial Officer and ... Relations. ® blood-based tests for colorectal cancer ...
(Date:11/30/2015)... LONDON , November 30, 2015 Mexico ... Healthcare and Life Sciences Report 2015 . --> Pharmaboardroom ... 2015 . Latin America , a country ... , a country of over 122 million people. --> ... in healthcare, pharmaceuticals, or life sciences insights into the second largest ...
(Date:11/30/2015)... SHELTON, Connecticut , November 30, 2015 ... Kentucky Breast Care has entered into a ... women,s healthcare practice. This will allow Kentucky Breast Care ... and offer exceptional care for their patients. ... Kentucky Breast Care has entered into a ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... The Progressive Dental ... on January 29 and 30, 2016. The course welcomes dental professionals and members ... to learn how to better succeed in the modern dental marketplace. The course ...
(Date:11/30/2015)... ... , ... A record crowd gathered at the Pennsylvania Biotech Center of Bucks ... Blumberg Institute. , The institute, which is the research arm of the Hepatitis B ... the conference, which focused on ways companies can work to reduce the cost and ...
(Date:11/30/2015)... ... 30, 2015 , ... HemoTreat™ has announced that the company ... to its website. , “Our goal is simple:” says Michael Blasco, HemoTreat’s Chief ... comparison chart and ingredient list allows our customers to quickly see why, and ...
(Date:11/30/2015)... ... November 30, 2015 , ... ChiliPad ... looking to maximize recovery through quality sleep. Tim DiFrancesco, training coach for the ... better night’s sleep. ChiliPad precisely regulates the surface temperature of each side of ...
(Date:11/30/2015)... ... November 30, 2015 , ... Advocare ... centered orthopedic care. Led by John Vitolo, M.D., the center offers their ... the team at Advocare Orthopedic & Sports Medicine is ready to help their ...
Breaking Medicine News(10 mins):